Literature DB >> 36018472

Best Practices for Designing Informative Trials Including Women.

Johny Nicolas1, Madison Edens1, Birgit Vogel1, Roxana Mehran2.   

Abstract

PURPOSE OF REVIEW: Despite mandates from funding agencies and professional societies to broaden inclusivity in medical research, women remain underrepresented in cardiovascular clinical trials. This lack of representation limits the generalizability of the findings and results in uncertainty about the safety and efficacy of many cardiovascular therapies in female patients. RECENT
FINDINGS: Several barriers impact women's participation in clinical trials, including enrollment criteria, common misconceptions, access to tertiary care, and women representation in clinical trial leadership. This short review discusses these barriers and suggests potential solutions to increase women's participation in clinical trials and improve their cardiovascular health.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiovascular health; Clinical trials; Equity; Women

Mesh:

Year:  2022        PMID: 36018472     DOI: 10.1007/s11883-022-01064-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.967


  12 in total

1.  Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study.

Authors:  Bernadet T Santema; Wouter Ouwerkerk; Jasper Tromp; Iziah E Sama; Alice Ravera; Vera Regitz-Zagrosek; Hans Hillege; Nilesh J Samani; Faiez Zannad; Kenneth Dickstein; Chim C Lang; John G Cleland; Jozine M Ter Maaten; Marco Metra; Stefan D Anker; Pim van der Harst; Leong L Ng; Peter van der Meer; Dirk J van Veldhuisen; Sven Meyer; Carolyn S P Lam; Adriaan A Voors
Journal:  Lancet       Date:  2019-08-22       Impact factor: 79.321

Review 2.  Cardiovascular Disease in Women: Clinical Perspectives.

Authors:  Mariana Garcia; Sharon L Mulvagh; C Noel Bairey Merz; Julie E Buring; JoAnn E Manson
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

Review 3.  The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.

Authors:  Wendy Tsang; David A Alter; Harindra C Wijeysundera; Tony Zhang; Dennis T Ko
Journal:  J Gen Intern Med       Date:  2011-06-29       Impact factor: 5.128

Review 4.  Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.

Authors:  Niti R Aggarwal; Hena N Patel; Laxmi S Mehta; Rupa M Sanghani; Gina P Lundberg; Sandra J Lewis; Marla A Mendelson; Malissa J Wood; Annabelle S Volgman; Jennifer H Mieres
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-02

Review 5.  Therapeutic implications of the gender-specific aspects of cardiovascular disease.

Authors:  Vera Regitz-Zagrosek
Journal:  Nat Rev Drug Discov       Date:  2006-05       Impact factor: 84.694

6.  Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.

Authors:  Pamela E Scott; Ellis F Unger; Marjorie R Jenkins; Mary Ross Southworth; Tzu-Yun McDowell; Ruth J Geller; Merina Elahi; Robert J Temple; Janet Woodcock
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

Review 7.  Symptom presentation of women with acute coronary syndromes: myth vs reality.

Authors:  John G Canto; Robert J Goldberg; Mary M Hand; Robert O Bonow; George Sopko; Carl J Pepine; Terry Long
Journal:  Arch Intern Med       Date:  2007-12-10

8.  Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care.

Authors:  Nakela L Cook; John Z Ayanian; E John Orav; Leroi S Hicks
Journal:  Circulation       Date:  2009-04-27       Impact factor: 29.690

Review 9.  Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives.

Authors:  Leslie Cho; Amanda R Vest; Michelle L O'Donoghue; Modele O Ogunniyi; Amy A Sarma; Kara J Denby; Emily S Lau; Jeanne E Poole; Kathryn J Lindley; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2021-08-17       Impact factor: 24.094

10.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao
Journal:  Circulation       Date:  2021-01-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.